Skip to main content
Equibles

Bette Jacobs

Board Member

Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Bette Jacobs

Bette Jacobs is recorded as Board Member at Shuttle Pharmaceuticals Holdings, Inc. (SHPH). Shuttle Pharmaceuticals Holdings, Inc. reported in an 8-K filed February 28, 2025 that Bette Jacobs resigned as director, effective February 28, 2025. Shuttle Pharmaceuticals Holdings, Inc. reported in an 8-K filed November 1, 2022 that Bette Jacobs was appointed independent director, effective November 1, 2022.

“On February 28, 2025 (i) each of Milton Brown, Bette Jacobs, Chris Senanayake and Joshua Shafer resigned as directors of the Company, and (ii) the Company's Board of Directors appointed George Scorsis, Joseph Tung, and Oleh Nabyt as directors of the Company.”
Shuttle Pharmaceuticals Holdings, Inc. Form 8-K, filed February 28, 2025 · Read the filing
“Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT), today announced the appointment of Dr. Bette Jacobs to its Board of Directors as an independent director.”
Shuttle Pharmaceuticals Holdings, Inc. Form 8-K, filed November 1, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Shuttle Pharmaceuticals Holdings, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.